Abstract
At present, with the frequent occurrence of cancer, especially malignant cancer, more and more scholars begin to pay attention to the treatment method, treatment effect, prognosis, and side effects of cancer. Anti-CTLA-4 immunosuppressive agents have become another pillar of the treatment of related cancers with high efficacy, low toxicity, and good prognosis. Research on Anti-CTLA-4 has never stopped. This article focuses on Anti-CTLA-4, summarizes the related mechanism, clinical treatment, and toxic side effects of CTLA-4, and hopes to provide a new research direction for researchers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
